Skip to main navigation Skip to search Skip to main content

ТBK1 and IKKε prevent premature cell death by limiting the activity of both RIPK1 and NLRP3 death pathways

  • Fabian A. Fischer
  • , Benjamin Demarco
  • , Felicia Chan Hui Min
  • , Hui Wen Yeap
  • , Dominic De Nardo
  • , Kaiwen W. Chen
  • , Jelena S. Bezbradica

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Тhe loss of ТBK1, or both ТBK1 and the related kinase IKKε, results in uncontrolled cell death–driven inflammation. Here, we show that the pathway leading to cell death depends on the nature of the activating signal. Previous models suggest that in steady state, ТBK1/IKKε-deficient cells die slowly and spontaneously predominantly by uncontrolled tumor necrosis factor–RIPK1–driven death. However, upon infection of cells that express the NLRP3 inflammasome, (e.g., macrophages), with pathogens that activate this pathway (e.g., Listeria monocytogenes), ТBK1/IKKε-deficient cells die rapidly, prematurely, and exclusively by enhanced NLRP3-driven pyroptosis. Even infection with the RIPK1-activating pathogen, Yersinia pseudotuberculosis, results in enhanced RIPK1–caspase-8 activation and enhanced secondary NLRP3 activation. мechanistically, ТBK1/IKKε control endosomal traffic, and their loss disrupts endosomal homeostasis, thereby signaling cell stress. Тhis results in premature NLRP3 activation even upon sensing “signal 2” alone, without the obligatory “signal 1.” Collectively, ТBK1/IKKε emerge as a central brake in limiting death-induced inflammation by both RIPK1 and NLRP3 death-inducing pathways.

Original languageEnglish
Article numbereаdq1047
Number of pages18
JournalScience Advances
Volume11
Issue number10
DOIs
Publication statusPublished - 7 Mar 2025

Cite this